Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study.

IF 2.1 4区 医学 Q3 ONCOLOGY Radiology and Oncology Pub Date : 2024-09-15 DOI:10.2478/raon-2024-0045
Nezka Hribernik,Katja Strasek,Daniel T Huff,Andrej Studen,Katarina Zevnik,Katja Skalic,Robert Jeraj,Martina Rebersek
{"title":"Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study.","authors":"Nezka Hribernik,Katja Strasek,Daniel T Huff,Andrej Studen,Katarina Zevnik,Katja Skalic,Robert Jeraj,Martina Rebersek","doi":"10.2478/raon-2024-0045","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nTo evaluate the role of the novel quantitative imaging biomarker (QIB) SUVX% of 18F-FDG uptake extracted from early 18F-FDG-PET/CT scan at 4 weeks for the detection of immune-related adverse events (rAE) in a cohort of patients with metastatic melanoma (mM) patients receiving immune-checkpoint inhibitors (ICI).\r\n\r\nPATIENTS AND METHODS\r\nIn this prospective non-interventional, one-centre clinical study, patients with mM, receiving ICI treatment, were regularly followed by 18F-FDG PET/CT. Patients were scanned at baseline, early point at week four (W4), week sixteen (W16) and week thirty-two (W32) after ICI initiation. A convolutional neural network (CNN) was used to segment three organs: lung, bowel, thyroid. QIB of irAE - SUVX% - was analyzed within the target organs and correlated with the clinical irAE status. Area under the receiver-operating characteristic curve (AUROC) was used to quantify irAE detection performance.\r\n\r\nRESULTS\r\nA total of 242 18F-FDG PET/CT images of 71 mM patients were prospectively collected and analysed. The early W4 scan showed improved detection only for the thyroid gland compared to W32 scan (p=0.047). The AUROC for detection of irAE in the three target organs was highest when SUVX% was extracted from W16 scan and was 0.76 for lung, 0.53 for bowel and 0.81 for thyroid. SUVX% extracted from W4 scan did not improve detection of irAE compared to W16 scan (lung: p = 0.54, bowel: p = 0.75, thyroid: p = 0.3, DeLong test), as well as compared to W32 scan in lungs (p = 0.32) and bowel (p = 0.3).\r\n\r\nCONCLUSIONS\r\nEarly time point 18F-FDG PET/CT at W4 did not lead to statistically significant earlier detection of irAE. However, organ 18F-FDG uptake as quantified by SUVX% proved to be a consistent QIB of irAE. To better assess the role of 18F-FDG PET/CT in irAE detection, the time evolution of 18F-FDG PET/CT quantifiable inflammation would be of essence, only achievable in multi centric studies.","PeriodicalId":21034,"journal":{"name":"Radiology and Oncology","volume":"30 1","pages":"335-347"},"PeriodicalIF":2.1000,"publicationDate":"2024-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology and Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/raon-2024-0045","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND To evaluate the role of the novel quantitative imaging biomarker (QIB) SUVX% of 18F-FDG uptake extracted from early 18F-FDG-PET/CT scan at 4 weeks for the detection of immune-related adverse events (rAE) in a cohort of patients with metastatic melanoma (mM) patients receiving immune-checkpoint inhibitors (ICI). PATIENTS AND METHODS In this prospective non-interventional, one-centre clinical study, patients with mM, receiving ICI treatment, were regularly followed by 18F-FDG PET/CT. Patients were scanned at baseline, early point at week four (W4), week sixteen (W16) and week thirty-two (W32) after ICI initiation. A convolutional neural network (CNN) was used to segment three organs: lung, bowel, thyroid. QIB of irAE - SUVX% - was analyzed within the target organs and correlated with the clinical irAE status. Area under the receiver-operating characteristic curve (AUROC) was used to quantify irAE detection performance. RESULTS A total of 242 18F-FDG PET/CT images of 71 mM patients were prospectively collected and analysed. The early W4 scan showed improved detection only for the thyroid gland compared to W32 scan (p=0.047). The AUROC for detection of irAE in the three target organs was highest when SUVX% was extracted from W16 scan and was 0.76 for lung, 0.53 for bowel and 0.81 for thyroid. SUVX% extracted from W4 scan did not improve detection of irAE compared to W16 scan (lung: p = 0.54, bowel: p = 0.75, thyroid: p = 0.3, DeLong test), as well as compared to W32 scan in lungs (p = 0.32) and bowel (p = 0.3). CONCLUSIONS Early time point 18F-FDG PET/CT at W4 did not lead to statistically significant earlier detection of irAE. However, organ 18F-FDG uptake as quantified by SUVX% proved to be a consistent QIB of irAE. To better assess the role of 18F-FDG PET/CT in irAE detection, the time evolution of 18F-FDG PET/CT quantifiable inflammation would be of essence, only achievable in multi centric studies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
定量成像生物标志物在早期 FDG-PET/CT 检测黑色素瘤患者免疫相关不良事件中的作用:一项前瞻性研究。
背景评估在接受免疫检查点抑制剂(ICI)治疗的转移性黑色素瘤(mM)患者队列中,从 4 周早期 18F-FDG-PET/CT 扫描中提取的新型定量成像生物标志物(QIB)18F-FDG 摄取 SUVX% 在检测免疫相关不良事件(rAE)方面的作用。患者与方法 在这项前瞻性、非干预、单中心临床研究中,接受 ICI 治疗的转移性黑色素瘤患者定期接受 18F-FDG PET/CT 随访。患者在基线、开始接受 ICI 治疗后第四周(W4)、第十六周(W16)和第三十二周(W32)的早期点接受扫描。使用卷积神经网络(CNN)对肺、肠和甲状腺三个器官进行分割。在目标器官内分析了虹膜睫状体E的QIB--SUVX%,并将其与临床虹膜睫状体E状态相关联。结果前瞻性地收集和分析了 71 名 mM 患者的 242 张 18F-FDG PET/CT 图像。与 W32 扫描相比,早期 W4 扫描仅提高了甲状腺的检测率(p=0.047)。从 W16 扫描中提取 SUVX%时,三个目标器官的irAE检测AUROC最高,肺部为0.76,肠道为0.53,甲状腺为0.81。与W16扫描相比,从W4扫描中提取的SUVX%并不能提高irAE的检出率(肺:p = 0.54,肠:p = 0.75,甲状腺:p = 0.3,DeLong检验),与W32扫描相比,肺(p = 0.32)和肠(p = 0.3)的检出率也没有提高。然而,以 SUVX% 定量的器官 18F-FDG 摄取被证明是irAE 的一致 QIB。为了更好地评估18F-FDG PET/CT在irAE检测中的作用,18F-FDG PET/CT量化炎症的时间演变至关重要,这只有在多中心研究中才能实现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Radiology and Oncology
Radiology and Oncology ONCOLOGY-RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
CiteScore
4.40
自引率
0.00%
发文量
42
审稿时长
>12 weeks
期刊介绍: Radiology and Oncology is a multidisciplinary journal devoted to the publishing original and high quality scientific papers and review articles, pertinent to diagnostic and interventional radiology, computerized tomography, magnetic resonance, ultrasound, nuclear medicine, radiotherapy, clinical and experimental oncology, radiobiology, medical physics and radiation protection. Therefore, the scope of the journal is to cover beside radiology the diagnostic and therapeutic aspects in oncology, which distinguishes it from other journals in the field.
期刊最新文献
Whole-body PET/MRI to detect bone metastases: comparison of the diagnostic performance of the sequences. Liver volumetry improves evaluation of treatment response to hepatic artery infusion chemotherapy in uveal melanoma patients with liver metastases. The initial results of MRI-TRUS fusion prostate biopsy in high volume tertiary center. [18F]fluorocholine PET vs. [99mTc]sestamibi scintigraphy for detection and localization of hyperfunctioning parathyroid glands in patients with primary hyperparathyroidism: outcomes and resource efficiency. Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1